Delhi Capitals (DC) join forces with MSD Pharmaceuticals

The Delhi Capitals (DC) have announced a partnership with MSD Pharmaceuticals, with the partnership set to focus on promoting awareness about cervical cancer and its prevention.

With this partnership, MSD Pharmaceuticals aims to use the growing popularity of the women’s game and the Women’s Premier League (WPL) to raise awareness about the “importance of preventive health and raise awareness about protecting oneself from cervical cancer”.

Sunil Gupta, Chief Executive Officer, Delhi Capitals, said:

“Women’s cricket has seen phenomenal growth, and we’re proud to use our platform to support a cause that can positively impact millions. This partnership with MSD allows us to champion cervical cancer awareness and encourage proactive health measures among women across the country.“

Rehan A. Khan, Managing Director, MSD India Region, added:

“Cervical cancer is preventable, yet it continues to impact thousands of women across India. At MSD, we are committed to empowering women with the knowledge and resources needed to take charge of their health. Partnering with Delhi Capitals provides us with a powerful platform to reach millions and drive meaningful action toward prevention and early detection. This collaboration is more than an awareness campaign—it’s a movement for a healthier future for women in India.“

Also read: IPL 2025 | Delhi Capitals SWOT Analysis